Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf (2018) Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy, ANNALS OF ONCOLOGY, vol. 29, br. 7, str. 1535-1540 (Article) 

Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin (2018) Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 28, br. 6, str. 1153-1161 (Article) 

Aapro Matti,Jordan Karin,Gralla Richard J,Rizzi Giada,Rossi Giorgia,Palmas Marco,Alyasova Anna V,Lisyanskaya Alla S,Bosnjak Snezana M,Hesketh Paul J (2017) Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients, JOURNAL OF GERIATRIC ONCOLOGY, vol. 8, br. 1, str. 56-63 (Article) 

Gralla RJ,Bosnjak Snezana M,Hontsa A,Balser C,Rizzi Giada,Rossi G,Borroni Maria Elisa,Jordan Karin (2014) A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy, ANNALS OF ONCOLOGY, vol. 25, br. 7, str. 1333-1339 (Article)